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Abstract
Amphotericin B (AmB) is the most widely used polyene antibiotic to treat systemic fungal infections which affect an
increasing number of immunocompromised patients. It is generally thought that AmB forms pores within the fungi
membranes by interacting with ergosterol, the main sterol of fungi. However, it also interacts with the cholesterol contained
in mammalian cells, hence its toxicity. In order to have a better understanding of the interactions prevailing between AmB
and sterols, differential scanning calorimetry was used to study various mixtures incorporating from 6.5 to 25 mol% of AmB
in pure dipalmitoylphosphatidylcholine (DPPC) vesicles and in ergosterol- or cholesterol-containing DPPC vesicles. The
sterol concentration was kept constant at 12.5 mol% with respect to the phospholipid. Our results show that three phases co-
exist when AmB is dispersed in the pure phospholipid. One corresponds to the phospholipid phase alone. The two others are
characterised by a broad transition at temperatures higher than the main transition temperature of the pure phospholipid,
corresponding to the drug in interaction with the aliphatic chains of the lipid. The fact that the transition temperatures of
these additional components are higher than that of the pure phospholipid suggests that AmB interacts strongly with the
aliphatic chains of the lipid, consistent with the idea prevailing in the literature that AmB by itself may form pores in a lipid
matrix. When AmB interacts with cholesterol-containing bilayers the thermograms also present three components. Upon
increasing the concentration of AmB, though, an important broadening of these components is observed which is explained
in terms of destabilisation of the organisation of the aliphatic chains. The situation is strikingly different if ergosterol is
present in the lipid matrix. The thermograms remain unmodified as the concentration of AmB is increased and a broad
transition, now involving only two components when the thermograms are decomposed, is observed. An analysis of the
results shows that various interacting units, e.g. AmB+DPPC and (AmB+ergosterol)+DPPC, are present within the
membrane. These units involve the phospholipid and hence contribute to its structurisation. The important differences
between the thermograms obtained with the ergosterol- as compared to the cholesterol-containing bilayers, in spite of the
structural similarity of these two sterols, provides strong evidence for the selectivity of interaction of AmB with ergosterol as
compared to cholesterol. It is thus clear that the action of AmB on cholesterol- as compared to ergosterol-containing
membranes results from different mechanisms. Finally, UV-visible spectra of AmB in pure as well as sterol-containing DPPC
vesicles show the presence of absorption bands that give support to the interpretation derived from the calorimetric data.
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1. Introduction
Amphotericin B (AmB) is the most potent and
e¡ective polyene antibiotic clinically available. It
has become the most widely used drug to treat seri-
ous systemic fungal infections, which have become
an important clinical problem owing to the increas-
ing number of immune-compromised patients [1,2].
Unfortunately, the classical formulation of AmB,
Fungizone, has negative side e¡ects (e.g. nephrotox-
icity) that seriously impair its e⁄cacy [3]. It has been
shown that AmB acts at the membrane level where it
increases the permeability of the cells to ions and
small molecules. This activity depends on the pres-
ence of sterols in the membrane [1,4] and it has been
proposed in the 1970s that the interaction between
membrane sterols and AmB is responsible for the
selectivity of the drug. It has therefore been assumed
that the selective toxicity of AmB for fungi results
from its capacity to bind more strongly to ergosterol,
the principal fungal sterol, than to cholesterol, the
principal sterol of mammalian cells [3,5].
Indeed, it has been suggested that AmB^sterol
complexes would exist in the cell membrane environ-
ment, an idea originating from the fact that such
complexes are present in aqueous solution [6^8]. It
is now generally admitted that in phospholipid mem-
branes, AmB associates with the sterols to form hy-
drophilic pores in which the AmB molecules are in a
quasi-parallel orientation, their polar side pointing
towards the inside of the pore and their lipophilic
part interacting with the lipid environment [9,10].
The presence of such structures in a cellular mem-
brane increases its permeability and causes damages
resulting ultimately to the death of the cell [10^14].
It has been shown that ergosterol-containing
membranes are more sensitive to the action of
AmB than cholesterol-containing membranes
[6,13,15^18] and as a consequence, the concentration
of AmB necessary to obtain the same permeabil-
ity is higher with cholesterol than with ergosterol
[13].
However, the detailed molecular mechanism of the
interaction of AmB with the membrane, as well as
the formation of a transmembrane pore structure,
are still imperfectly understood. In fact, in the light
of recent observations, it appears that the mechanism
of action of AmB on a cellular membrane is more
complex than previously thought. For instance, in-
teractions of AmB with the various components of
the cell membrane (e.g. lipids and proteins), inducing
lipid peroxidation [19], inhibition of membrane
pumps [20,21], blockade of endocytosis and immune
stimulation [22], have been invoked.
When studies are made with model membranes,
the situation does not seem to be simpler and contra-
dictory results are found in the literature. For exam-
ple, Fujii et al. [23] have shown that sterols are not
mandatory for the formation of AmB channels
across the lipid membrane and thus that AmB may
interact speci¢cally with phospholipids, in contradic-
tion with results previously published by Ockman
[24]. On the other hand, Bolard et al. [25] have
shown that when large unilamellar vesicles of egg
phosphatidylcholine are exposed to the action of
AmB, only the ergosterol- but not the cholesterol-
containing membranes show the presence of pores,
thereby implying that the action of AmB on choles-
terol-containing membranes involves a di¡erent
mechanism. This is in contradiction with the work
done by Butyan and McPhie [26], who have shown
that both cholesterol- and ergosterol-containing
BLMs form channels of the same molecular struc-
ture, with the di¡erence that the ergosterol^AmB
channels have longer open-channel lifetimes.
In this context, in order to shed some light on the
interactions between AmB, phospholipids and the
sterols, we have performed di¡erential scanning cal-
orimetric studies on dipalmitoylphosphatidylcholine
(DPPC) vesicles containing AmB or containing
AmB and either cholesterol or ergosterol. The results
show that AmB by itself induces a phase separation
within the membrane, as clearly evidenced by the
presence of new components in the thermogram at
temperatures higher than that of the pure DPPC. In
addition, when AmB is added to cholesterol- or er-
gosterol-containing DPPC vesicles, the thermograms
of the two series of mixtures are completely di¡erent,
although the e¡ect of the sterols themselves on the
thermogram of DPPC is the same. These results are
interpreted in terms of the selectivity of interaction of
AmB with the two sterols. We also show that the
results are consistent with the presence of AmB^er-
gosterol units (or complexes) within the membrane
matrix that have a structural ordering e¡ect on their
lipid environment.
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2. Materials and methods
2.1. Materials
AmB, cholesterol, ergosterol and dimethyl sulph-
oxide (DMSO) were purchased from Sigma (St.
Louis, MO). 1,2-Dipalmitoyl-sn-glycero-3-phospho-
choline (DPPC, powder) was purchased from Avanti
Polar Lipids (Alabaster, Al). Chloroform was ob-
tained from Anachemia (spectroscopic grade, Mon-
treal, Que.). The water used to prepare all the solu-
tions was distilled and demineralised on a Sybron-
Barnstead system (Fisher Scienti¢c, Montreal, Que.).
Phosphate bu¡er (PBS) 0.02 M at pH 7.0 was used
for the liposome preparation.
2.2. Preparation of the liposome solutions
DPPC, ergosterol and cholesterol are ¢rst dis-
solved in chloroform while AmB is solubilised in
the smallest volume of DMSO possible. From these
batch solutions, a solution at the ¢nal concentration
of the various components is prepared in a volumet-
ric £ask. The solvent is then evaporated (Rotovapor
R 110, Buechi-Brinkman, Germany) to dryness and
the lipid ¢lm is resuspended in the PBS bu¡er. It was
veri¢ed by FTIR spectroscopy that at the concentra-
tions used, DMSO was completely removed from the
suspension during the evaporation. Large unilamellar
vesicles are prepared from this lipid suspension
through four freeze^thaw cycles, the high tempera-
ture of the cycle being at 50‡C, i.e. higher than the
main transition temperature of DPPC. In all cases,
the ¢nal lipid concentration used was 4 mg/ml
(5.45U1033 M) while the concentration of the sterol
was ¢xed at 12.5 mol% with respect to the phospho-
lipid. Three di¡erent concentrations of AmB were
used: 6.25, 12.5 and 25 mol% with respect to the
lipid. The UV-visible spectra taken from the super-
natant solution when the vesicles are centrifuged in-
dicate that more than 98% of the AmB is indeed
incorporated in the vesicles.
2.3. Di¡erential scanning calorimetry
The thermograms were recorded on a Hart Scien-
ti¢c Di¡erential Scanning Calorimeter (Calorimetry
Sciences, Provo, UT) from 20 to 60‡C at a scan rate
of 10‡C/h. The thermogram of the bu¡er used is
subtracted from the thermogram obtained and then
corrected for the thermal delay of the calorimeter.
The decomposition of the thermograms was obtained
by further processing the data using the software
‘SPECTRA+’ [27], based on algorithms developed
by Barwicz et al. [28,29]. The software provided us
with the parameters of the thermogram under study
(magnitude, transition temperature, area under the
peaks, half-height width, notably).
The molar enthalpy of the transition was calcu-
lated from the total area under the peak divided by
the total number of moles of DPPC in the prepara-
tion. Each thermogram has been done at least three
times to ensure reproducibility.
2.4. Absorption UV-visible spectroscopy
The UV-visible spectra were recorded against the
pure PBS bu¡er on a Spectronic 3000 Array spectro-
photometer (Milton Roy, Armonk, NY) using a 0.1-
cm cell, the resolution being 0.35 nm.
3. Results and discussion
The thermograms of pure DPPC (4 mg/ml, curve
A), DPPC plus cholesterol (curve B) or ergosterol
(curve C) are presented in Fig. 1. The thermogram
obtained here for the pure DPPC shows a ¢rst ther-
mal transition at 33.5‡C, corresponding to the pre-
transition of the lipid, and a second transition at
41.4‡C, corresponding to the main gel to liquid^crys-
talline phase transition. Our thermogram is identical
to those found in the literature for DPPC [30,31].
Fig. 1 also indicates that the e¡ect of cholesterol or
ergosterol (at the concentration used here, 12.5
mol%) on the thermogram of the phospholipid is
almost identical: in both cases, the pretransition is
abolished and the main transition peak is decreased,
broadened and shifted to lower temperatures (40.5‡C
in both cases). Our results for the mixed cholester-
ol+DPPC vesicles are in close agreement with the
literature data [31], while those with ergosterol have
not been reported so far. It would therefore seem
that the two sterols, considering the similarity of
their molecular structure and the similarity of their
thermograms when mixed with DPPC, would act in
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the same way towards the lipid. Upon insertion of
the sterol within the hydrophobic region of the phos-
pholipid (it is generally admitted that the sterol is
inserted paralleled to the aliphatic chains of the lip-
id), a disruption of the molecular interactions pre-
vailing between the aliphatic chains results, thus
yielding to a broadening of the main transition
peak and a shift of this peak towards lower temper-
atures. These features correspond to what is gener-
ally expected when additives are mixed to a lipid.
A closer look at Fig. 1 also reveals that the tran-
sition peak of the lipid mixed with either sterol is not
symmetrical. This feature is in agreement with the
thermograms of DPPC mixed with cholesterol re-
cently published by McMullen et al. [31] and Vist
and Davis [32]. Indeed, the decomposition of the
DSC endotherms (Fig. 1, dotted lines) shows the
superimposition of a sharp and a broad component,
the former being associated to the melting of sterol-
poor regions within the bilayer while the latter is
associated to the melting of sterol-rich DPPC do-
mains. The striking similarity between the endo-
therms when ergosterol or cholesterol are mixed
with DPPC suggests that for ergosterol also, poor-
and rich-ergosterol regions would be found within
the bilayer. However, a complete phase diagram of
ergosterol mixed with DPPC would be necessary to
clarify this situation, a task beyond the goal of the
present work.
The e¡ect of AmB itself on the thermogram of
DPPC is shown in Fig. 2. In order to compare the
results, the thermogram of the pure lipid is also re-
produced in Fig. 2A while Fig. 2B^D present the
results obtained for the mixtures at increasing con-
centrations of the drug (i.e. 6.25, 12.5 and 25 mol%).
As the concentration of the drug increases, one ob-
serves that the pretransition and the main transition
peaks of the lipid are decreased without a¡ecting the
transition temperatures or the cooperativity of the
transition (this latter point will be discussed along
with Fig. 6). The thermograms of the mixtures
show that two new phase transitions are appearing
at temperatures higher than that of the pure phos-
pholipid. One is centred at 42.6‡C, this phase taking
more importance as the concentration of AmB in-
creases. The second one is broad, centred at
V46‡C. Its importance is also function of the
amount of AmB present in the bilayer although
Fig. 2B^D do not present this feature properly. To
clarify this point, Fig. 2 (right upper corner) also
presents one of the thermograms (thermogram C)
drawn to a di¡erent scale which shows more clearly
the presence of the component at V46‡C. It is thus
Fig. 2. Thermograms of DPPC vesicles incorporating AmB. A,
DPPC; B, DPPC+AmB 6.25 mol%; C, DPPC+AmB 12.5
mol%; D, DPPC+AmB 25 mol%. Dotted lines: the components
of the decomposed thermograms. The thermograms are dis-
placed vertically for more clarity. Upper left : the molecular
structure of AmB. Upper right: as curve C, but drawn to a dif-
ferent scale.
Fig. 1. The e¡ect of cholesterol and ergosterol on the thermo-
tropic phase behaviour of DPPC. A, DPPC; B, DPPC+12.5
mol% cholesterol ; C, DPPC+12.5 mol% ergosterol. Dotted
lines: the components of the decomposed thermograms. The
thermograms are displaced vertically for more clarity.
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clear that three phases are co-existing when AmB is
dispersed in the phospholipid, one corresponding ex-
actly to the pure lipid phase alone (the main transi-
tion temperature of the pure DPPC is indeed ob-
served in the thermograms even at 25 mol% of
AmB), the others, characterised by broad transitions,
corresponding to the lipid phase in interaction with
the drug.
In order to rationalise the e¡ect of AmB on the
thermotropic transitions of the lipid, it might be im-
portant to recall that AmB is an amphiphilic mole-
cule with a very special rigid structure: the hydro-
phobic side contains seven conjugated double bonds
while the hydrophilic side contains several polar sub-
stituents (see insert, Fig. 2). It is generally admitted
that in phospholipid membranes the AmB molecules
are present as aggregates and form hydrophilic pores
[9,10]. In this con¢guration, the lipophilic parts of
AmB molecules are in contact with the aliphatic
chains of the phospholipid molecules while the polar
groups of AmB are located on the inner side of the
pore, forming hydrogen bonds with water molecules.
Such a molecular organisation provides ideal condi-
tions for a rigidifying action of the acyl chains of the
lipid by AmB through enhanced Van der Waals in-
teractions. At the drug concentrations presented in
this paper it is more than probable that the AmB
molecules contained in the DPPC vesicles are indeed
organised as aggregates as suggested by Fuji [23],
these aggregates, in the light of the current literature
on AmB, being most likely what is referred to pores.
Therefore, the fact that our mixtures present phase
separations, together with the fact that the temper-
atures of the new transitions observed are higher
than that of the pure phospholipid strongly suggest
that AmB has a rigidifying e¡ect on the hydrophobic
part of the membrane which could directly result
from the molecular arrangement of the drug within
the bilayer, as discussed above.
The ability of AmB to rigidify its lipid environ-
ment has also been invoked by others in the litera-
ture. For instance Dufourc et al. [33], from 2H-NMR
studies on DMPC liposomes containing AmB, have
noted a monotonic ordering e¡ect of all the positions
along the acyl chain of DMPC in contact with AmB.
This ordering e¡ect has also been suggested to ex-
plain the permeability results obtained with DPPC
liposomes [34,35]. In addition, from an analysis of
CD spectra of AmB in sterol-free vesicles, Balakrish-
nan et al. [36] have proposed the existence of an
organised multimolecular structure within the bi-
layer, in which AmB interacts with the acyl chains,
forming a 1:1 complex. This complex would form a
non-aqueous pre-pore structure according to an hy-
pothesis brought by Cohen [35]. In fact, the idea that
AmB by itself, in the absence of sterols, would form
pores within the membrane has been inferred by dif-
ferent authors in the literature [37^40]. In the light of
the results presented here, however, it is clear that
the presence of such units within the membrane
would contribute to rigidify the lipid environment.
Although, as discussed, what is known about AmB
dispersed within membranes does suggest that the
drug could have a rigidifying e¡ect on the lipid en-
vironment, it is not possible to completely rule out
the fact that the increase in the transition temper-
ature we observe might also be interpreted in terms
of mismatch e¡ect between AmB and its lipid envi-
ronment. Indeed, according to Zhang et al. [41] the
hydrophobic thickness of the bilayer formed by
DPPC in the gel state is 39.4 Aî . The length of the
hydrophobic part of the AmB molecule is close to 20
Aî [42], thus corresponding almost exactly to the hy-
drophobic thickness of one layer of the DPPC mem-
brane in the gel state. On the other hand, during the
main transition, the mismatch between the hydro-
phobic length of an AmB molecule and the hydro-
phobic thickness of the DPPC bilayer (32.9 Aî on
average in the phase transition [41]) cannot be ex-
cluded. However, the e¡ect of mismatch is suggested
here as an additional, but minor e¡ect and cannot
replace, in our opinion, the important rigidifying ef-
fect of AmB. In this sense, both e¡ects could con-
tribute to the increase of the transition temperature
observed.
The e¡ect of AmB on the DPPC bilayer contain-
ing 12.5 mol% cholesterol is presented in Fig. 3,
which also presents the decomposition of the endo-
therms. To ensure an easier comparison of the re-
sults, Fig. 3A reproduces the thermogram of the lipid
containing 12.5 mol% of cholesterol (i.e. Fig. 1B)
while Fig. 3B^D represent the thermograms of the
cholesterol-containing DPPC bilayers in the presence
of increasing concentrations of AmB (6.25, 12.5 and
25 mol%, Fig. 3B^D, respectively). At 6.25 mol% of
AmB (Fig. 3B), the decomposed thermogram also
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shows that a phase separation is occurring, one of
the phases being DPPC in interaction with the sterol
(the endotherm at 40.5‡C in Fig. 3B corresponds to
the endotherm in Fig. 3A), the other phases present-
ing transition temperatures at 42.3 and V46‡C.
These phases may correspond either to DPPC in in-
teraction with AmB (the peaks in Fig. 3B are found
at the same temperatures as those observed in Fig.
2B^D for the binary AmB+DPPC mixtures) or may
also correspond to DPPC+cholesterol in interaction
with AmB.
However, as the concentration of AmB is in-
creased from 6.25 to 25 mol%, the transitions at
40.5, 42.3 and V46‡C are broadened and shifted
towards lower temperatures, a point that will be pre-
sented further (Fig. 6). This indicates an important
destabilisation of the organisation of the aliphatic
chains of the phospholipid. Since neither cholesterol
alone at the concentration used here (Fig. 1B) or at
higher concentrations (up to 25 mol%, [31,32]), nor
AmB (Fig. 2B^D) present such an e¡ect when mixed
with DPPC, one must conclude that the destabilizing
e¡ect observed in Fig. 3C,D results from the pres-
ence of the two components, AmB and cholesterol,
simultaneously within the bilayer. The fact that we
observe separated phases when AmB is incorporated
in cholesterol-containing lipid vesicles is consistent
with the results reported by Balakrishnan and Eas-
waran [36] and Fujii et al. [23]. Thus, the general
behaviour of the various peaks as the concentration
of AmB is increased in presence of cholesterol, is
di¡erent from what was observed when AmB itself
was mixed with DPPC (Fig. 2). This shows how
cholesterol may perturb the interactions between
AmB and the phospholipid.
Strikingly di¡erent results are obtained if choles-
terol is substituted for ergosterol in the membrane.
Fig. 4A presents the thermogram of DPPC contain-
ing 12.5 mol% ergosterol while Fig. 4B^D show the
thermograms of the ergosterol-containing DPPC bi-
layers in the presence of increasing concentrations of
AmB (6.25, 12.5 and 25 mol%). One notes that the
thermograms for the ternary mixtures are very sim-
ilar for the various AmB concentrations used. A
broad transition, centred at about 42.7‡C, is re-
corded which remains unmodi¢ed when the concen-
tration of AmB is increased by a factor of 4. The
transition temperature observed here for the ternary
mixtures is similar to the one found in Fig. 2B^D
when AmB alone was mixed with the lipid. In addi-
tion, the decomposition of the thermograms shows a
small, broad transition at about 40.5‡C which corre-
Fig. 4. The e¡ect of AmB on the thermotropic phase behaviour
of DPPC vesicles containing 12.5 mol% ergosterol. A,
DPPC+12.5 mol% ergosterol. From B to D, the bilayer con-
tains in addition 6.25, 12.5 and 25 mol% of AmB. Dotted lines:
the components of the decomposed thermograms. The thermo-
grams are displaced vertically for more clarity.
Fig. 3. The e¡ect of AmB on the thermotropic phase behaviour
of DPPC vesicles containing 12.5 mol% cholesterol. A,
DPPC+12.5 mol% cholesterol. From B to D, the bilayer con-
tains in addition 6.25, 12.5 and 25 mol% of AmB. Dotted lines:
the components of the decomposed thermograms. The thermo-
grams are displaced vertically for more clarity.
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sponds to the transition temperature observed for the
binary ergosterol+DPPC mixture. The important dif-
ferences between the thermograms obtained with the
ergosterol- as compared to the cholesterol-containing
bilayers, in spite of the structural similarity of these
two sterols, bring a strong evidence for the selectivity
of interaction of AmB with ergosterol- as compared
to cholesterol-containing lipid bilayers. Such a selec-
tivity of interaction with sterol-containing systems
has also been observed by us in a previous work
using monolayers [43].
The fact that the thermograms of ergosterol and
DPPC incorporating various amounts of AmB re-
main almost unmodi¢ed upon increasing the concen-
tration of AmB by a factor of 4 is an important
result. It is certainly not accidental either that the
broad transition recorded for the ternary mixtures
studied here (Fig. 4B^D) is centred around the
same temperature (42.7‡C) as the phase transition
recorded when AmB by itself is dispersed in DPPC
(Fig. 2B^D). In this latter case, as discussed above,
the phase transition was associated to the presence of
regions enriched in AmB within the bilayer in which
the lipid is organised by its interactions with AmB.
In addition, the observation that the magnitude of
the peak at 40.5‡C associated to the ergosterol^lipid
interactions is so much decreased even for the lowest
concentration of AmB used (Fig. 4B) strongly sug-
gests that AmB interacts favourably with ergosterol
thus diminishing the amount of ergosterol molecules
free to interact with the lipid. The situation was in-
deed completely di¡erent when cholesterol was
present in the bilayer. In this latter case, the peak
at 40.5‡C corresponding to the lipid in interaction
with the sterol was always clearly present (Fig. 3B)
and contributed signi¢cantly to the overall transition
recorded in this case. On the other hand, the corre-
sponding peak when ergosterol is used almost disap-
pears and becomes included in a broad transition
centred at 42.7‡C. Also, the fact that this latter
peak is much broader than the peak observed at
the same temperature when AmB itself interacts
with DPPC (compare Fig. 2D to Fig. 4D) indicates
that the cooperativity of the transition is much low-
er. This shows that various interacting units, e.g.
AmB+DPPC and (AmB+ergosterol)+DPPC, might
be present within the membrane which rigidify their
lipid environment, the transition being again ob-
served at temperatures higher than the main transi-
tion temperature of DPPC. This is also a strong in-
dication that the lipid is involved in the interactions
with AmB and ergosterol, an idea which is reinforced
when one realises that, as the concentration of AmB
is increased up to two molecules of AmB per mole-
cule of ergosterol (Fig. 4D), one still observes that
the broad transition is not modi¢ed.
The analysis of our results can be pushed further
by calculating the overall transition enthalpy for all
the systems studied, as presented in Fig. 5. The total
molar enthalpy obtained for the pure DPPC is about
34.0 kJ/mol, a value in agreement with the data ob-
tained by McElhaney et al. (32.4 kJ/mol, [31]) and
Finegold et al. (36.4 kJ/mol, [44]). In the presence of
12.5 mol% of either sterol alone, the molar enthalpy
of the lipid decreases to 25.0 kJ/mol for the choles-
terol-containing DPPC vesicles, a value in agreement
with the literature, V24 kJ/mol [31]. For the ergo-
sterol-containing DPPC vesicles, on the other hand,
the value obtained is 28.2 kJ/mol (data not available
in the literature). The di¡erent enthalpy values for
these two systems suggest that, in similar conditions,
the perturbing action of cholesterol on the phospho-
lipid chains is more important than that of ergosterol
even though the temperature of the main transition
in both cases is almost the same (Fig. 1).
When AmB is introduced either in the lipid alone
or in the sterol-containing vesicles, the general ten-
dency observed is that the molar enthalpy of the
overall transition is decreased, although the situation
is not that clear for the ergosterol-containing vesicles.
Indeed, the decrease in the molar enthalpy observed
Fig. 5. The e¡ect of AmB on the total molar enthalpy.
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when the concentration of AmB is increased up to 25
mol% is about 10 kJ/mol for either the pure DPPC
or the cholesterol containing vesicles while the de-
crease is only 4 kJ/mol for the ergosterol-containing
vesicles. One also notes that at 12.5 mol% AmB or
higher the molar enthalpy for the pure DPPC or the
ergosterol-containing vesicles is about the same. So,
what is observed here is the e¡ect of the ergosterol^
AmB complexes on the overall thermotropic transi-
tion of the phospholipid, a situation which is strik-
ingly di¡erent from what is observed when cholester-
ol instead is present in the bilayer (compare the
results of Fig. 5 for the ergosterol and cholesterol-
containing bilayers). In the latter case, the results
obtained can be interpreted as representing the sum
of both the e¡ects of AmB and cholesterol on the
lipid.
The decomposition of our thermograms allows us
to investigate the detailed e¡ect of the incorporation
of AmB on either the main transition temperatures
or the cooperativity of the transitions (half-height
width), as shown in Fig. 6A and B, respectively. In
Fig. 6, the various peaks resulting from the decom-
position of the thermograms of Figs. 2^4 are identi-
¢ed by a number referring to the position of the
peaks and a code identifying the system under study.
Thus 1-Chol refers to the peak centred at 40.5‡C for
the cholesterol-containing lipid vesicles while 3-
DPPC, for example, refers to the peak centred at
V46‡C for the sterol-free DPPC. The positions of
the various peaks are thus plotted as a function of
the AmB concentration.
Fig. 6A shows that the transition temperatures of
the various peaks of the decomposed thermograms
do not vary, generally, as the concentration of AmB
is increased. The only exception is when 12.5 mol%
cholesterol and AmB are present in the bilayer. In
this case, the transition temperature associated to the
¢rst peak is decreased by about 1.5‡C (1-Chol) while
the decrease is about 0.6 and 0.9 for the second (2-
Chol) and third peak (3-Chol), respectively. This was
explained above by the important destabilisation of
the organisation of the aliphatic chains of the phos-
pholipid due to the presence of both AmB and chol-
esterol in the membrane.
Fig. 6B presents the cooperativity of the various
transitions observed for all the systems studied. In-
asmuch as the ¢rst component of the transitions is
concerned, Fig. 6B (1-DPPC, 1-Chol, 1-Erg) shows
that the half-height width of the transition when no
AmB is present is minimal and almost the same for
the three systems, V0.5‡C, thereby implying that the
cooperativity of the transitions is high, and similar.
However, when AmB is introduced in these systems,
the half-height width of the transition is changed
dramatically (rising from 0.5‡C to 3.5‡C) for the er-
gosterol containing vesicles while it increases by less
than 1‡C for the cholesterol containing ones and
does not vary at all for the sterol-free DPPC vesicles.
Fig. 6. The e¡ect of AmB on the various components of the
thermograms for all the systems studied plotted as a function
of the concentration of AmB. (A) Transition temperature. (B)
Half-height width. The curves are identi¢ed by a number refer-
ring to the various components of the decomposed thermo-
grams and a code identifying the system under study. Thus 1-
Chol refers to the peak centred at 40.5‡C for the cholesterol-
containing lipid vesicles (Fig. 3) while 3-DPPC refers to the
peak centred at V46‡C for the sterol-free DPPC (Fig. 2).
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Therefore, the cooperativity of the transition for the
ergosterol containing vesicles is much lower than that
of the cholesterol or sterol free vesicles. As was ex-
plained above, this can be rationalised by the fact
that AmB has a high a⁄nity for ergosterol, with
the consequence that the peak (centred at 40.5‡C)
attributed to the lipid in interaction with the sterol
is broadened and almost disappears. In addition, the
fact that for the ergosterol-containing vesicles the
cooperativity increases when concentrations of
AmB are higher than 12.5% may suggest that aggre-
gation of the AmB/ergosterol complexes occurs with-
in the lipid matrix, as it is often the case when pro-
teins are present in a bilayer [41].
The second component of the transitions has a
di¡erent behaviour. In this case, the half-height
widths for the sterol-containing bilayers (Fig. 6B, 2-
Chol and 2-Erg) are similar, both being in the range
of 3^4‡C, but in the presence of ergosterol, the values
are slightly higher. With the sterol-free lipid vesicles
(2-DPPC) the half-height width is lower, around 2‡C.
Thus, when either cholesterol or ergosterol are
present within the lipid matrix together with AmB,
the cooperativity of the transition is lower than when
AmB alone is dispersed within the lipid matrix. As
noted above, however, the perturbing e¡ect is more
important with ergosterol than with cholesterol. Fi-
nally, Fig. 6B also presents the half-height widths of
the third component of the transitions (3-DPPC, 3-
Chol). However, the magnitude of these transition
components is small and thus the changes of the
half-height widths when the concentration of AmB
is varied are more di⁄cult to interpret.
In order to probe the interactions of AmB with
DPPC, ergosterol and cholesterol, we have also
used UV-visible spectroscopy. This latter technique
is particularly useful since it has been shown to be
particularly sensitive to the aggregation state of AmB
as well as to the interaction of the drug with its
molecular environment. For instance, AmB in the
monomeric state has a speci¢c spectrum with a max-
imum of absorption at 409 nm, while in the aggre-
gated state this maximum is shifted to 421 nm [45].
Fig. 7A presents the UV-visible spectra for DPPC
mixed with AmB (6.25 mol%) while Fig. 7B and C
present the absorption spectra for cholesterol- and
ergosterol-containing DPPC vesicles, respectively, in-
corporating the same amount of AmB with respect
to the lipid. In the last two mixtures ergosterol and
cholesterol were present at 12.5 mol% with respect to
the lipid, as it was the case for the calorimetric stud-
ies. It is clear from Fig. 7A that the band at 415.2
nm, which is not observed in the spectrum of either
the monomeric or aggregated forms of AmB, results
from the interaction of the drug with its lipid envi-
ronment. In this sense, the spectrum con¢rms the
interaction of AmB with the aliphatic chains shown
in Fig. 2. Furthermore, Fig. 7B and C show the
presence of a band at 414.9 and at 416.3 nm for
the cholesterol- and ergosterol-containing liposomes,
respectively. Control spectra of binary mixtures of
AmB mixed with cholesterol showed an absorption
band at 414.9 nm while spectra of binary mixtures of
AmB mixed with ergosterol presented an absorption
band at 416.3 nm (results not shown). Thus the band
observed at 416.3 nm in the ergosterol-containing
DPPC vesicles (Fig. 7C) is associated to the interac-
tions of AmB with ergosterol, a result consistent with
the calorimetric data discussed above. On the other
hand the band at 414.9 nm in the cholesterol-con-
taining vesicles (Fig. 7B) cannot be unambiguously
attributed to the cholesterol^AmB interactions due
to the proximity of the band attributed to the
AmB^lipid interactions positioned at 415.2 nm.
In conclusion, our calorimetric data have shown
Fig. 7. UV-visible spectra of AmB incorporated into lipid
vesicles. A, AmB+DPPC; B, AmB in cholesterol-containing
DPPC vesicles ; C, AmB in ergosterol-containing DPPC vesicles.
In all cases, AmB was present as 6.25 mol% with respect to
DPPC.
BBAMEM 77404 1-8-98
I. Fournier et al. / Biochimica et Biophysica Acta 1373 (1998) 76^8684
that AmB, owing to both its rigidity and the way it is
positioned within the membrane structures the ali-
phatic chains of DPPC. As a consequence these
chains interact more importantly, through van der
Waals interactions, with AmB than the aliphatic
chains of the lipid with themselves. Thus, in this
sense, one can say that the aliphatic chains of the
lipid are rigidi¢ed upon their interaction with the
drug. These results are consistent with the idea that
AmB may form aggregates or pores within the bi-
layer, even in the absence of sterols. On the other
hand, we have shown an important selectivity of
the interactions of AmB with ergosterol- as com-
pared to cholesterol-containing bilayers. This implies
that the action of AmB on cholesterol- with respect
to ergosterol-containing membranes results from dif-
ferent mechanisms, notably due to the fact that only
the ergosterol- but not the cholesterol-containing
membranes show the presence of pores, as suggested
by Bolard et al. [25]. Current experiments now being
pursued in our laboratory using other techniques
(FTIR and 2H-NMR), together with further DSC
experiments using a larger range of concentrations
of both AmB and sterols, shall soon con¢rm the
structurisation e¡ect of AmB on the aliphatic chains
of its lipid environment.
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